LSPA On Demand

Tell Me About Your DE&I Initiatives

Tell Me About Your DE&I Initiatives welcomes individuals from organizations within the life sciences to discuss their culture, hiring practices, and managing the changing landscape of the workplace. This program evolved from the student-facing Tell Me About Your Job program. To view on-demand recordings from Tell Me About Your Job, CLICK HERE.

Panel Discussion on changing DE&I landscape:

• Cristina Lara, DE&I and People Relations Partner, Biogen
• Peter Leahy, Channel Leader, Marketing, Kimberley-Clark
• Amy Provost, Head of Talent Management, Novocure
• Moderator – Laura Yehuda, Partner, Ernst & Young

Panel Discussion

• Natasha Berry, Vice President of Inclusion Culture, Diversity & Equity, Smith + Nephew
• Jasmin Senior Bostic, Associate Director, Global Early Careers Program (US & EMEA), CSL Behring
• Nithya Srinivasan, Director of Marketing, Rheumatology, Janssen

Panel Discussion

• Delvina Morrow, Senior Director, Strategic Community Initiatives and DEI with the Pittsburgh Penguins
• Mary Walker, Vice President Human Resources at PECO
• Sumit Verma, Senior Vice President Commercial Manufacturing, Iovance Biotherapeutics, Inc. 
• Moderated by Amy Dorfmeister, Partner, Ernst and Young

Panel Discussion

• Marcia O’Connor, Founder & CEO, The O’Connor Group
• Peter Leahy, Channel Leader, Marketing, Kimberly Clark Professional
• Joseph Lingle, Chief People Officer, Center for Breakthrough Medicines

Panel Discussion

• Rashida Dujue-Jackson, CEO, Diversitas
• Mindy Geib, Director of Strategic HR Services, MidAtlantic Employees’ Association
• Ed Seiders, Director of Business Development, 20/20 Visual Media

Finance Operations Series

The Finance Operations Series welcomes experts from KPMG for quarterly educational sessions to discuss the current financial landscape and give actionable tips on navigating everyday financial challenges for members.

In this session, various KPMG tax partners and professionals will discuss what companies across the Life Sciences industry are facing with regard to the ERC and other federal and state incentives for the coming year as well as the tax considerations of a remote workforce.

In this session, various KPMG tax partners and professionals will discuss what companies across the Life Sciences industry are facing with regard to recent economic developments as well as industry trends in state, local, and value-added tax considerations.

This edition will focus on audits of financial statements, deferred compensation and 409A compensation, and Pennsylvania state budget considerations and what they mean for the R&D credit pool.

After attending this session, participants should be able to:

• Describe the key aspects and challenges of a global location and expansion analysis specific to Life Sciences
• Identify qualifying research activities and expenses in the Life Sciences industry for the Research and Development Tax Credit.
• Identify various corporate business incentives and evaluate whether they may benefit your organization
• Discuss VAT considerations for clinical trials in order to maximize import VAT recovery, determine reporting obligations, and apply exemption or other reliefs

• Summarize key tax considerations of IP planning from start-up to commercialization and how transfer pricing may play a role in the process
• Discuss the importance of collaboration and financial agreements in planning for the operational phase
• Discuss jurisdictional planning considerations related to the above

LAW – Legal Answers Workshop

The Legal Answers Workshop welcomes experts from Ballard Spahr to give actionable answers and tips to members on all sides of legal challenges and opportunities.

In our kick-off to the series, this session tackles common challenges in protecting innovation in the life sciences arenas, to successfully protect your business’ objectives. Hear from experienced Ballard Spahr speakers who have decades of experience helping their clients navigate an ever-evolving IP landscape on a range of topics germane to your business.

Licensing Agreements and Partnering

Moderator: Ryan Udell, Partner

During Episode 2 of this series, we will discuss best practices in licensing and partnering agreements.  Hear from veteran Ballard Spahr lawyers, who have decades of experience working on these types of transactions in the life sciences industry, as they discuss:

• Different types of licensing agreements from foundational, to clinical stage, to commercialization, including sponsored research and materials transfer agreements, development and collaborations, and commercialization arrangements

• Best practices for structuring your transaction to align with your business goals

• Commons terms and provisions

• Licensor and Licensee Perspectives

For our last LAW session of the year, our moderator Ryan Udell was joined by two of his Ballard Spahr partners, Meredith Dante and Brian Pinheiro, as they discuss top of mind employment issues and incentive compensation structures and strategies to help you continue to navigate the rapidly evolving post-Covid environment.

The Art of Fundraising

The Art of Fundraising welcomes experts from Danforth Advisors to give tips to companies on fundraising, building trusted advisor relationships, creating a team, and more!

Experts from Danforth Advisors will give advice on raising capital for your organization. This will focus on the different stages of fundraising as well as providing real life examples.

The Art of Fundraising Series – Preparing for the Seed Round 

Program description:
Hear from industry experts on how you should prepare to start looking for seed funding.  Topics covered will include:

• Checklist for preparing for a seed round
• Seed round investors
• Popular forms of seed funding –  Convertible notes and SAFEs
• And more!

Phase-to-Phase: The Guide to Drug Development

Experts from FlowMetric will discuss the discovery stage, including target identification & validation, hit identification, and lead discovery & optimization

Session Topic – Discovery: The do’s and don’t’s, experience perspective, and recognition of workarounds that enable the process. 

• Target Identification
• Target Validation
• Hit Identification/Lead Discovery
• Assay Development
• Lead Optimization

Speakers:

• Mark Tornetta, MS, Vice President of Lead Discovery, Tavotek Biotherapeutics
• Dominic Warrino, Ph.D., Senior Scientific Adviser, KCAS Bioanalytical & Biomarker Services
• Moderator: Ren Capocasale, Vice Chair & Founder, FlowMetric, a KCAS company